Goodpasture syndrome historical perspective
Goodpasture syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Goodpasture syndrome historical perspective On the Web |
American Roentgen Ray Society Images of Goodpasture syndrome historical perspective |
Risk calculators and risk factors for Goodpasture syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]
Overview
Goodpasture syndrome was first discovered by Dr.Ernest William Goodpasture, an American pathologist and physician, who studied the influenza pandemic in 1919, described a fatal disease that was associated with glomerulonephritis and pulmonary hemorrhage.
Historical Perspective
- The name Goodpasture's syndrome was first coined in 1957 in Melbourne, Australia by Stanton and Tange to describe 9 patients who presented with glomerulonephritis along with pulmonary hemorrhage.[1]
- However, In a book titled "Earnest William Goodpasture: Scientist, Scholar, Gentelman" by Dr. Robert D. Collins, Dr. Goodpasture believed that the name of this syndrome should not be named after him as he deemed it inappropriate as he had not studied the disease.[2][3]
- However, the name was adopted and is used today when describing the syndrome.
References
- ↑ STANTON MC, TANGE JD (1958). "Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis)". Australas Ann Med. 7 (2): 132–44. PMID 13546112.
- ↑ Collins RD (2010). "Dr Goodpasture: "I was not aware of such a connection between lung and kidney disease"". Ann Diagn Pathol. 14 (3): 194–8. doi:10.1016/j.anndiagpath.2010.02.003. PMID 20471565.
- ↑ Self S (2009). "Goodpasture's 1919 article on the etiology of influenza-the historical road to what we now call Goodpasture Syndrome". Am J Med Sci. 338 (2): 154. doi:10.1097/MAJ.0b013e3181acbd55. PMID 19680022.